• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病理淋巴结比率是食管癌患者生存的预测指标:一项基于文献的汇总分析。

Pathologic lymph node ratio is a predictor of esophageal carcinoma patient survival: a literature-based pooled analysis.

作者信息

Zhao Yuming, Zhong Shengyi, Li Zhenhua, Zhu Xiaofeng, Wu Feima, Li Yanxing

机构信息

Department of Cardiothoracic Surgery, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning 437100, China.

出版信息

Oncotarget. 2017 Jul 15;8(37):62231-62239. doi: 10.18632/oncotarget.19258. eCollection 2017 Sep 22.

DOI:10.18632/oncotarget.19258
PMID:28977940
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5617500/
Abstract

The positive lymph node ratio (LNR) has been suggested as a predictor of survival in patients with esophageal carcinoma (EC). However, existed evidences did not completely agree with each other. We sought to examine whether LNR was associated with overall survival (OS). Electronic database was searched for eligible literatures. The primary outcome was the relationship between LNR and OS, which was presented as hazard ratio (HR) with 95% confidence intervals (CIs). All statistical analyses were performed using STATA 11.0 software. A total of 18 relevant studies which involved 7,664 cases were included. Patients with an LNR of 0.3 or greater had an increased risk of death compared to those with an LNR of less than 0.3(HR = 2.33; 95% CI 2.03-2.68; P<0.01). Similarly, patients with an LNR greater than 0.5 was also associated with a decreased OS(HR = 1.95; 95% CI 1.52-2.50; P<0.01). No publication bias was found. This meta-analysis confirmed that LNR was a significant predictor of survival in patients with EC and should be considered in prognostication.

摘要

阳性淋巴结比率(LNR)已被认为是食管癌(EC)患者生存的一个预测指标。然而,现有证据并不完全一致。我们试图研究LNR是否与总生存期(OS)相关。通过检索电子数据库查找符合条件的文献。主要结局是LNR与OS之间的关系,以风险比(HR)及95%置信区间(CI)表示。所有统计分析均使用STATA 11.0软件进行。共纳入18项相关研究,涉及7664例患者。与LNR小于0.3的患者相比,LNR为0.3或更高的患者死亡风险增加(HR = 2.33;95%CI 2.03 - 2.68;P<0.01)。同样,LNR大于0.5的患者OS也降低(HR = 1.95;95%CI 1.52 - 2.50;P<0.01)。未发现发表偏倚。这项荟萃分析证实,LNR是EC患者生存的一个重要预测指标,在预后评估中应予以考虑。

相似文献

1
Pathologic lymph node ratio is a predictor of esophageal carcinoma patient survival: a literature-based pooled analysis.病理淋巴结比率是食管癌患者生存的预测指标:一项基于文献的汇总分析。
Oncotarget. 2017 Jul 15;8(37):62231-62239. doi: 10.18632/oncotarget.19258. eCollection 2017 Sep 22.
2
The Prognostic Significance of Lymph Node Ratio for Esophageal Cancer: A Meta-Analysis.淋巴结比率对食管癌的预后意义:一项荟萃分析。
J Surg Res. 2023 Dec;292:53-64. doi: 10.1016/j.jss.2023.07.027. Epub 2023 Aug 14.
3
Lymph Node Ratio as a Prognostic Marker in Rectal Cancer Survival: A Systematic Review and Meta-Analysis.淋巴结比率作为直肠癌生存预后标志物的系统评价与Meta分析
Cureus. 2020 May 10;12(5):e8047. doi: 10.7759/cureus.8047.
4
The prognostic values of lymph node ratio for gynecological cancer: a systematic review and meta-analysis.淋巴结比率对妇科癌症的预后价值:一项系统评价和荟萃分析。
Front Oncol. 2024 Oct 1;14:1475348. doi: 10.3389/fonc.2024.1475348. eCollection 2024.
5
Pathologic lymph node ratio is a predictor of survival in esophageal cancer.病理性淋巴结比率是食管癌生存的预测因子。
Ann Thorac Surg. 2012 Nov;94(5):1643-51. doi: 10.1016/j.athoracsur.2012.03.078. Epub 2012 May 22.
6
Prognostic value of lymph node ratio in patients with pathological N1 non-small cell lung cancer: a systematic review with meta-analysis.淋巴结比率对病理 N1 期非小细胞肺癌患者预后的价值:系统评价与荟萃分析。
Transl Lung Cancer Res. 2016 Jun;5(3):258-64. doi: 10.21037/tlcr.2016.06.13.
7
Prognostic value of lymph node ratio in stage IIIC epithelial ovarian cancer with node-positive in a SEER population-based study.基于监测、流行病学和最终结果(SEER)人群研究的IIIC期上皮性卵巢癌伴淋巴结阳性患者中淋巴结比率的预后价值
Oncotarget. 2016 Feb 16;7(7):7952-9. doi: 10.18632/oncotarget.6911.
8
Lymph node ratio is a prognostic factor for non-small cell lung cancer.淋巴结比率是非小细胞肺癌的一个预后因素。
Oncotarget. 2015 Oct 20;6(32):33912-8. doi: 10.18632/oncotarget.5669.
9
Prognostic Significance of Lymph Node Ratio in Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck.淋巴结比率在头颈部转移性皮肤鳞状细胞癌中的预后意义
Ann Surg Oncol. 2016 May;23(5):1693-8. doi: 10.1245/s10434-015-5070-6. Epub 2016 Jan 19.
10
The intrathoracic lymph node ratio seems to be a better prognostic factor than the level of lymph node involvement in lung metastasectomy of colorectal carcinoma.对于结直肠癌肺转移瘤切除术,胸内淋巴结比率似乎是比淋巴结受累水平更好的预后因素。
Interact Cardiovasc Thorac Surg. 2015 Feb;20(2):215-21. doi: 10.1093/icvts/ivu364. Epub 2014 Oct 30.

引用本文的文献

1
Integrating knowledge graphs into machine learning models for survival prediction and biomarker discovery in patients with non-small-cell lung cancer.将知识图谱集成到机器学习模型中,以预测非小细胞肺癌患者的生存情况并发现生物标志物。
J Transl Med. 2024 Aug 5;22(1):726. doi: 10.1186/s12967-024-05509-9.
2
History and evidence for state of the art of lymphadenectomy in esophageal cancer surgery.食管癌手术中淋巴结清扫术的历史和现状。
Dis Esophagus. 2024 Apr 2;37(4). doi: 10.1093/dote/doad065.
3
A Population-Based Study to Evaluate the Associations of Nodal Stage, Lymph Node Ratio and Log Odds of Positive Lymph Nodes with Survival in Patients with Small Bowel Adenocarcinoma.

本文引用的文献

1
Prognostic role of the lymph node ratio in node positive colorectal cancer: a meta-analysis.淋巴结比率在淋巴结阳性结直肠癌中的预后作用:一项荟萃分析。
Oncotarget. 2016 Nov 8;7(45):72898-72907. doi: 10.18632/oncotarget.12131.
2
Lymph node ratio-based staging system as an alternative to the current TNM staging system to assess outcome in adenocarcinoma of the esophagogastric junction after surgical resection.基于淋巴结比率的分期系统作为当前TNM分期系统的替代方案,用于评估食管胃交界腺癌手术切除后的预后。
Oncotarget. 2016 Nov 8;7(45):74337-74349. doi: 10.18632/oncotarget.11188.
3
Assessment of Lymph Node Ratio to Replace the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma.
一项基于人群的研究,旨在评估小肠胃腺癌患者的淋巴结分期、淋巴结比率和阳性淋巴结对数比值与生存的相关性。
Curr Oncol. 2022 Feb 22;29(3):1298-1308. doi: 10.3390/curroncol29030110.
4
The Lymph Node Ratio Is an Independent Prognostic Factor in Esophageal Cancer Patients Who Receive Curative Surgery.淋巴结转移率是接受根治性手术的食管癌患者的独立预后因素。
In Vivo. 2020 Jul-Aug;34(4):2087-2093. doi: 10.21873/invivo.12012.
5
TRANSHIATAL ESOPHAGECTOMY IS NOT ASSOCIATED WITH POOR QUALITY LYMPHADENECTOMY.经胸食管切除术与淋巴结清扫质量不佳无关。
Arq Bras Cir Dig. 2019 Dec 20;32(4):e1475. doi: 10.1590/0102-672020190001e1475. eCollection 2019.
评估淋巴结比率以取代食管癌 TNM 系统的 pN 分类系统。
J Thorac Oncol. 2016 Oct;11(10):1774-84. doi: 10.1016/j.jtho.2016.06.019. Epub 2016 Jul 5.
4
Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer.阳性淋巴结的对数比值可预测食管癌切除术后患者的生存率。
Ann Thorac Surg. 2016 Aug;102(2):424-32. doi: 10.1016/j.athoracsur.2016.03.030. Epub 2016 May 13.
5
Lymph node ratio is a prognostic factor for non-small cell lung cancer.淋巴结比率是非小细胞肺癌的一个预后因素。
Oncotarget. 2015 Oct 20;6(32):33912-8. doi: 10.18632/oncotarget.5669.
6
Extent of Lymphadenectomy and Prognosis After Esophageal Cancer Surgery.食管癌手术后淋巴结清扫范围与预后
JAMA Surg. 2016 Jan;151(1):32-9. doi: 10.1001/jamasurg.2015.2611.
7
Lymph Node Ratio as an Alternative to the Number of Metastatic Lymph Nodes for the Prediction of Esophageal Carcinoma Patient Survival.淋巴结比率作为转移性淋巴结数量的替代指标用于预测食管癌患者的生存率
Dig Dis Sci. 2015 Sep;60(9):2771-6. doi: 10.1007/s10620-015-3681-1. Epub 2015 May 5.
8
Effect of the number of positive lymph nodes and lymph node ratio on prognosis of patients after resection of pancreatic adenocarcinoma.阳性淋巴结数量及淋巴结比率对胰腺腺癌切除术后患者预后的影响。
Hepatobiliary Pancreat Dis Int. 2014 Dec;13(6):634-41. doi: 10.1016/s1499-3872(14)60264-2.
9
Prognostic significance of lymph node ratio in esophageal cancer.食管癌中淋巴结比率的预后意义
Tumour Biol. 2015 Apr;36(4):2335-41. doi: 10.1007/s13277-014-2840-x. Epub 2014 Nov 21.
10
Clinicopathological features and prognosis of gastric cardia adenocarcinoma: a multi-institutional US study.贲门腺癌的临床病理特征与预后:一项美国多机构研究
J Surg Oncol. 2015 Mar;111(3):285-92. doi: 10.1002/jso.23799. Epub 2014 Oct 10.